JuliusKielaitis \/ Shutterstock.com <\/p>\n
In his July 14 investor letter, Krishna said clients spent the final weeks of June rushing to secure supply-constrained servers, storage and memory before expected price increases. Cybersecurity concerns also competed for budgets and attention. IBM did capture some of that spending: Distributed Infrastructure revenue jumped 37%. But that strength was overwhelmed by weakness elsewhere. Several large deals slipped beyond the quarter, while IBM Z and its related Transaction Processing software missed expectations. To sum it up, the AI boom didn’t really miss IBM; it’s just that the money hit the wrong side of its portfolio at the wrong time. <\/p>\n
That timing hit a stock priced for reinvention. Reuters Breakingviews noted that IBM has spent more than $50 billion since 2018 on buying Red Hat, HashiCorp, and Confluent. Before IBM released the preliminary figures, its shares traded at roughly 26 times forward earnings after more than doubling in five years. Its generative AI book had reached $12.5 billion, while first-quarter software revenue grew 11%. The second quarter’s 5% growth therefore challenged the premise supporting IBM’s rerating. Oppenheimer, which had modeled 12% software growth, responded by downgrading the stock and abandoning its $350 target. <\/p>\n
IBM Is a Hold, Not a Buy Yet <\/p>\n
Smart-money positioning was mixed before the crash. At the end of the first quarter, 59 hedge funds in Insider Monkey’s database owned IBM, down from 64 in the previous quarter, although their combined holdings rose 27% to 6.76 million shares. AQR more than doubled its stake, D.E. Shaw increased its position 80%, and Millennium cut its common-stock holding 54%. Meanwhile, short interest rose 14.5% by June 30 to 34.28 million shares, or 3.66% of the float. Skepticism was building, but IBM was not a crowded short. Both datasets predate the July 14 collapse. <\/p>\n
That makes IBM a hold, not a stock to buy, simply because it fell 25%. Red Hat grew 11%, AI lifted Consulting signings, and the z17 cycle remains alive, so selling after the collapse looks late. But the miss also broke the software-growth case supporting IBM’s premium. New investors should wait until the slipped deals actually close and software growth recovers from 5%. If both happen without a cut to full-year targets, the selloff was excessive. If not, IBM did not become cheap on July 14; the market simply removed a valuation premium the business no longer deserved. <\/p>\n
While we acknowledge the risk and potential of IBM as an investment, our conviction lies in the belief that some other AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than IBM and that has 10,000% upside potential, check out our report about the cheapest AI stock<\/a>. <\/p>\n READ NEXT: 33 Stocks That Should Double in 3 Years<\/a> and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy<\/a>. <\/p>\n